San Francisco, CA – September 23, 2024 – VeriSIM Life was named a finalist in the Most Innovative Company of the Year category in the 21st annual Stevie® Awards for Women in Business. The Stevie Awards for Women in Business honor women executives, entrepreneurs, employees and the companies they run, worldwide. VeriSIM Life was founded in 2017 by Dr. Jo Varshney. The Stevie Awards have been hailed as the world’s premier business awards.
More than 1,500 entries from organizations and individuals in 36 nations and territories were submitted this year for consideration in more than 100 categories. Finalists were determined by the average scores of more than 200 business professional judges around the world, working on six juries. Their scores will also determine the Gold, Silver, and Bronze Stevie Award placements that will be revealed in November.
VeriSIM Life earned Most Innovative Company of the Year recognition for its work in addressing the decades-old “translational gap” challenge, which results in new drug candidates failing in clinical trials 95% of the time. This incredibly high failure rate results in billions of dollars of wasted research, driving up the cost of the drugs that do ultimately get approved for patient treatment. VeriSIM Life combats this issue with an innovative blend of artificial intelligence and biosimulation technology that directs scientists and researchers where to focus their experimentation and investment, resulting in much faster and less expensive drug development. The company’s platform, BIOiSIM, is the only solution of its type to address the full preclinical lifecycle of a drug asset – from discovery, through development and into clinical trials. Unlike AI-native drug developers that focus on chemical discovery, VeriSIM Life incorporates AI techniques with biosimulation to bring biological relevance to drug discovery as well as downstream R&D.
“We are excited and honored to be selected as a Stevie Awards winner in the category of Most Innovative Company of the Year, and congratulate all of the other companies nominated as well. It is a humbling reflection of our team’s commitment to our mission. To a person, we are deeply convicted to use technology to make a meaningful difference for patients in need awaiting live-saving therapeutics,” says Dr. Varshney, VeriSIM Life Founder & CEO.
“In its 21st year, the Stevie Awards for Women in Business received an impressive collection of remarkable nominations,” said Maggie Miller, president of the Stevie Awards. “We look forward to recognizing the outstanding achievements of women in the workplace in New York on November 8.”
Details about the Stevie Awards for Women in Business and the list of Finalists in all categories are available at www.StevieAwards.com/Women.
Gold, Silver, and Bronze Stevie Award winners will be announced during a gala event at the Marriott Marquis Hotel in New York City on Friday, November 8. Nominated women executives and entrepreneurs from around the world are expected to attend. The event will be broadcast on Livestream.
About VeriSIM Life
VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to improve drug discovery and development by significantly reducing the time and money it takes to bring a drug to market. BIOiSIM® is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. The platform predicts the likelihood of a candidate's success in clinical trials early in the preclinical stage, while reducing unnecessary experimentation and better informing key program decisions. For more information, visit www.verisimlife.com.
About The Stevie Awards
Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, The American Business Awards®, The International Business Awards®, the Middle East & North Africa Stevie Awards, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, the Stevie Awards for Sales & Customer Service, and the Stevie Awards for Technology Excellence. Stevie Awards competitions receive more than 12,000 nominations each year from organizations in more than 70 nations and territories. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at www.StevieAwards.com.
AtlasGEN Novel Drug Designer efficiently identifies new molecules based on favorable chemical properties and simultaneously evaluates them for clinical safety and effectiveness based on biology using VeriSIM Life’s groundbreaking Translational Index™ technology.
Iterative ranking of target engaging hits by their Translational Index values reduces the time and cost associated with other computational hit discovery approaches, while compressing the hit-to-lead refinement and optimization process by pre-validating hits for translatability. This unique integration dramatically reduces the number of compounds to evaluate in subsequent experimental research.
The ability to generate target engaging compound hits depends largely on the size of the molecular search library. The AtlasGEN search space is supported by more than 1 trillion compounds. Generative AI and deep learning techniques deliver unprecedented discovery capability.
AtlasGEN accurately predicts protein-lygand binding affinity by combining geometric conformer analysis with machine learning based on experimental data 72% more efficiently than molecular docking-based approaches.
.png)
